Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jacob Heitler"'
Autor:
Kelly M. Morgan, Jada G. Hamilton, Heather Symecko, Daniella Kamara, Colby Jenkins, Jenny Lester, Kelsey Spielman, Lydia E. Pace, Camila Gabriel, Jeffrey D. Levin, Prince Rainier Tejada, Anthony Braswell, Vanessa Marcell, Temima Wildman, Bryan Devolder, Robin Camhi Baum, Jeremy N. Block, Yuri Fesko, Kylin Boehler, Victoria Howell, Jacob Heitler, Mark E. Robson, Katherine L. Nathanson, Nadine Tung, Beth Y. Karlan, Susan M. Domchek, Judy E. Garber, Kenneth Offit
Publikováno v:
Genetics in medicine : official journal of the American College of Medical Genetics, vol 24, iss 3
Genet Med
Genet Med
PurposeThis study aimed to evaluate uptake and follow-up using internet-assisted population genetic testing (GT) for BRCA1/2 Ashkenazi Jewish founder pathogenic variants (AJPVs).MethodsAcross 4 cities in the United States, from December 2017 to March
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3283c07b2c89d138d0c553ef9e9ede4
https://escholarship.org/uc/item/3g27c893
https://escholarship.org/uc/item/3g27c893
Autor:
Kenneth Offit, Kelly Morgan, Daniella Kamara, Judy Garber, Jada G. Hamilton, Heather Symecko, Mark E. Robson, Temima Wildman, Jacob Heitler, Yuri Anthony Fesko, Nadine Tung, Susan M. Domchek, Katherine L. Nathanson, Jenny Lester, Lydia E. Pace, Jeffrey Levin, Beth Y. Karlan, Kelsey Spielman, Colby Jenkins, Vanessa Marcell
Publikováno v:
Journal of Clinical Oncology. 38:2007-2007
2007 Background: NCCN now endorses BRCA founder mutation genetic testing (GT) via longitudinal studies in all Ashkenazi Jewish (AJ) individuals. The BRCA Founder OutReach (BFOR) study offers pre-GT online education with posttest engagement of primary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eccea4f3e8f08da467fa4f7a9dc79824
https://doi.org/10.1200/jco.2020.38.15_suppl.2007
https://doi.org/10.1200/jco.2020.38.15_suppl.2007
Autor:
Mark E. Robson, Jenny Lester, Daniella Kamara, Lydia E. Pace, Jacob Heitler, Jeffrey Levin, Nadine Tung, Heather Symecko, Kenneth Offit, Colby Jenkins, Susan M. Domchek, Kelly Morgan, Beth Y. Karlan, Camila Gabriel, Judy Garber, Yuri Anthony Fesko, Jada G. Hamilton, Kelsey Spielman, Jeremy Block, Katherine L. Nathanson
Publikováno v:
Journal of Clinical Oncology. 37:1578-1578
1578 Background: Barriers to population screening for BRCA mutations include access, availability of counseling, and readiness of care providers to participate in this process. The BRCA Founder OutReach (BFOR) study evaluates a digital approach to ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2c7d211b56715f369730efa2a70ccb1
https://doi.org/10.1200/jco.2019.37.15_suppl.1578
https://doi.org/10.1200/jco.2019.37.15_suppl.1578
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.